Form 8-K - Current report:
SEC Accession No. 0001213900-25-011369
Filing Date
2025-02-07
Accepted
2025-02-07 16:52:01
Documents
16
Period of Report
2025-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230288-8k_180life.htm   iXBRL 8-K 37861
2 FIRST AMENDMENT TO SEPARATION AND RELEASE AGREEMENT DATED FEBRUARY 5, 2025, BETW ea023028801ex10-1_180life.htm EX-10.1 29577
3 VOTING AGREEMENT DATED FEBRUARY 5, 2025, BETWEEN 180 LIFE SCIENCES CORP., JAMES ea023028801ex10-2_180life.htm EX-10.2 31866
  Complete submission text file 0001213900-25-011369.txt   337934

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20250204.xsd EX-101.SCH 3787
5 XBRL DEFINITION FILE atnf-20250204_def.xml EX-101.DEF 26629
6 XBRL LABEL FILE atnf-20250204_lab.xml EX-101.LAB 36680
7 XBRL PRESENTATION FILE atnf-20250204_pre.xml EX-101.PRE 25253
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0230288-8k_180life_htm.xml XML 5810
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 25602624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)